MSD India’s

DCGI approves MSD India’s drug Keytruda for treatment of triple-negative breast cancer

Hyderabad, Oct 25 : MSD pharmaceutical (known as Merck in U.S. and Canada), on Wednesday announced that the Drug Controller…

Read More »